Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Short-term Investments (2021 - 2023)

Terns Pharmaceuticals' Short-term Investments history spans 3 years, with the latest figure at $228.7 million for Q3 2023.

  • For Q3 2023, Short-term Investments rose 83.98% year-over-year to $228.7 million; the TTM value through Sep 2023 reached $228.7 million, up 83.98%, while the annual FY2022 figure was $139.9 million, 18.26% up from the prior year.
  • Short-term Investments reached $228.7 million in Q3 2023 per TERN's latest filing, up from $204.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $228.7 million in Q3 2023 to a low of $96.8 million in Q1 2021.
  • Average Short-term Investments over 3 years is $135.1 million, with a median of $118.3 million recorded in 2021.
  • Peak YoY movement for Short-term Investments: rose 4.69% in 2022, then skyrocketed 83.98% in 2023.
  • A 3-year view of Short-term Investments shows it stood at $118.3 million in 2021, then rose by 18.26% to $139.9 million in 2022, then surged by 63.5% to $228.7 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Short-term Investments are $228.7 million (Q3 2023), $204.7 million (Q2 2023), and $113.2 million (Q1 2023).